| Tumor-specific IL-9–producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers Y Lu, B Hong, H Li, Y Zheng, M Zhang, S Wang, J Qian, Q Yi Proceedings of the National Academy of Sciences 111 (6), 2265-2270, 2014 | 144 | 2014 |
| Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma Y Li, Y Zheng, T Li, Q Wang, J Qian, Y Lu, M Zhang, E Bi, M Yang, F Reu, ... Oncotarget 6 (27), 24218, 2015 | 86 | 2015 |
| p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction J He, Z Liu, Y Zheng, J Qian, H Li, Y Lu, J Xu, B Hong, M Zhang, P Lin, ... Cancer research 72 (24), 6393-6402, 2012 | 80 | 2012 |
| p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion B Hong, H Li, M Zhang, J Xu, Y Lu, Y Zheng, J Qian, JT Chang, J Yang, ... International journal of cancer 136 (1), 34-43, 2015 | 66 | 2015 |
| Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9 M Zhang, C Dai, H Zhu, S Chen, Y Wu, Q Li, X Zeng, W Wang, J Zuo, ... Molecular and cellular biochemistry 357, 387-395, 2011 | 64 | 2011 |
| Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance S Chen, M Zhang, H Ma, H Saiyin, S Shen, J Xi, B Wan, L Yu Cancer chemotherapy and pharmacology 61, 459-469, 2008 | 63 | 2008 |
| p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression Y Lu, M Zhang, S Wang, B Hong, Z Wang, H Li, Y Zheng, J Yang, ... Nature communications 5 (1), 4229, 2014 | 61 | 2014 |
| Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy J Park, H Li, M Zhang, Y Lu, B Hong, Y Zheng, J He, J Yang, J Qian, Q Yi Cancer Immunology, Immunotherapy 63, 835-845, 2014 | 46 | 2014 |
| Human Osteoclasts Are Inducible Immunosuppressive Cells in Response to T cell–Derived IFN‐γ and CD40 Ligand In Vitro H Li, Y Lu, J Qian, Y Zheng, M Zhang, E Bi, J He, Z Liu, J Xu, JY Gao, Q Yi Journal of Bone and Mineral Research 29 (12), 2666-2675, 2014 | 42 | 2014 |
| USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity B Hong, H Li, Y Lu, M Zhang, Y Zheng, J Qian, Q Yi Molecular cancer 13, 1-12, 2014 | 38 | 2014 |
| Anti-β2-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy M Zhang, J He, Z Liu, Y Lu, Y Zheng, H Li, J Xu, H Liu, J Qian, ... Oncotarget 6 (11), 8567, 2015 | 29 | 2015 |
| Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity S Chen, X Zhao, J Tan, H Lu, Z Qi, Q Huang, X Zeng, M Zhang, S Jiang, ... European journal of pharmacology 565 (1-3), 54-59, 2007 | 26 | 2007 |
| Characterization of a novel human CDK5 splicing variant that inhibits Wnt/β-catenin signaling Q Li, X Liu, M Zhang, G Ye, Q Qiao, Y Ling, Y Wu, Y Zhang, L Yu Molecular biology reports 37, 2415-2421, 2010 | 23 | 2010 |
| Cyclophilin J is a novel peptidyl-prolyl isomerase and target for repressing the growth of hepatocellular carcinoma J Chen, S Chen, J Wang, M Zhang, Z Gong, Y Wei, L Li, Y Zhang, X Zhao, ... PLoS One 10 (5), e0127668, 2015 | 21 | 2015 |
| Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression Z Liu, J Xu, H Li, Y Zheng, J He, H Liu, Y Zhong, Y Lu, B Hong, M Zhang, ... PloS one 8 (12), e82453, 2013 | 20 | 2013 |
| Discovery of a potent peptidic cyclophilin A inhibitor Trp-Gly-Pro X Pang, M Zhang, L Zhou, F Xie, H Lu, W He, S Jiang, L Yu, X Zhang European journal of medicinal chemistry 46 (5), 1701-1705, 2011 | 17 | 2011 |
| The conditioned medium from a stable human GDF3-expressing CHO cell line, induces the differentiation of PC12 cells Q Li, X Liu, Y Wu, J An, S Hexige, Y Ling, M Zhang, X Yang, L Yu Molecular and cellular biochemistry 359, 115-123, 2012 | 16 | 2012 |
| SNIP1: a new activator of HSE signaling pathway Q Li, J An, X Liu, M Zhang, Y Ling, C Wang, J Zhao, L Yu Molecular and cellular biochemistry 362, 1-6, 2012 | 12 | 2012 |
| Characterization of a novel human HMBOX1 splicing variant lacking the homeodomain and with attenuated transcription repressor activity M Zhang, S Chen, Q Li, Y Ling, J Zhang, L Yu Molecular biology reports 37, 2767-2772, 2010 | 9 | 2010 |
| Anti‐β2M monoclonal antibodies kill myeloma cells via cell‐and complement‐mediated cytotoxicity M Zhang, J Qian, Y Lan, Y Lu, H Li, B Hong, Y Zheng, J He, J Yang, Q Yi International journal of cancer 135 (5), 1132-1141, 2014 | 8 | 2014 |
